Latest stories on ACET
Adicet data update presents attractive opportunity, says H.C. Wainwright
The Fly63 · neutralproduct/pr
Adicet Bio Highlights Prula-cel Autoimmune CAR-T Pipeline Progress
TipRanks63 · neutralproduct/pr
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral
Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
Adicet Bio completes last patient visit for analysis of prula-cel in lupus
The Fly59 · neutralproduct/pr
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Adicet Bio Gets FDA Clearance For Phase 1 Trial of Prostate Cancer Treatment
Morningstar67 · bullishproduct/pr
Adicet Bio Announces FDA Clearance of IND Application for ADI-212
StockTitan67 · bullishproduct/pr
Adicet Bio: A Cheap Gamma Delta T-Cell Play
Seeking Alpha58 · neutralanalyst
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral
Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
StockTitan55 · neutralearnings
Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference
StockTitan55 · neutralgeneral
Adicet Bio Stockholders Back Directors, Pay and Auditor
TipRanks50 · neutralgeneral
Adicet Bio, Inc. (ACET) files 8-K
SEC 8-K50 · neutralgeneral
ACET: [10-K/A] Adicet Bio, Inc. Amends Annual Report
StockTitan SEC50 · neutralgeneral
Adicet Bio GAAP EPS of -$1.88 beats by $1.20
Seeking Alpha56 · neutralearnings
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
Morningstar50 · neutralearnings